Clinical Trials Directory

Trials / Completed

CompletedNCT00456352

Duodenal Exclusion for the Treatment of T2DM

Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes Mellitus (T2DM)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Medtronic - MITG · Industry
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

Evaluation of duodenal exclusion procedure for the treatment of T2DM

Conditions

Interventions

TypeNameDescription
PROCEDUREduodenal exclusion

Timeline

Start date
2007-04-01
Primary completion
2009-04-01
Completion
2010-10-01
First posted
2007-04-04
Last updated
2014-08-22

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00456352. Inclusion in this directory is not an endorsement.